• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病的 DIY 系统:家庭和提供者的视角。

Do-It-Yourself (DIY) Systems in Diabetes: A Family and Provider Perspective.

机构信息

Center for Diabetes and Endocrinology, University of Maryland Midtown Campus, Baltimore, MD, USA.

Individual Contributor, Hagerstown, MD, USA.

出版信息

J Diabetes Sci Technol. 2020 Sep;14(5):917-921. doi: 10.1177/1932296820906204. Epub 2020 Mar 5.

DOI:10.1177/1932296820906204
PMID:32131623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7753847/
Abstract

Type 1 diabetes is a unique disorder, requiring constant and vigilant assessment of glucose levels, food/snacks consumed, activities and exercise, emotions and stress, hormonal influence, and illness. No other diagnosis is as intensive in terms of the "burden" of care that impacts the patient/family physiologically, cognitively, and psychologically. Several Do-It-Yourself (DIY) closed-loop systems currently exist and can provide options for patients and families looking to reduce the burden of type 1 diabetes. However, as the systems are not Food and Drug Administration approved, healthcare providers are faced with the decision of whether to support patients using DIY systems. This manuscript discusses the ethics of choice and patient autonomy from the perspective of patient/family and healthcare provider. A set of proposed guidelines for healthcare providers are also presented for consideration when interacting with a patient or family who desires to use a DIY system to help manage type 1 diabetes.

摘要

1 型糖尿病是一种独特的疾病,需要持续、警惕地评估血糖水平、所摄入的食物/零食、活动和运动、情绪和压力、激素影响以及疾病。没有其他诊断像 1 型糖尿病那样,在影响患者/家庭生理、认知和心理的“负担”方面如此密集。目前有几种 DIY 闭环系统,可以为寻求减轻 1 型糖尿病负担的患者和家庭提供选择。然而,由于这些系统未经食品和药物管理局批准,医疗保健提供者面临着是否支持使用 DIY 系统的患者的决策。本文从患者/家庭和医疗保健提供者的角度讨论了选择和患者自主权的伦理问题。还提出了一套针对医疗保健提供者的建议指南,以供在与希望使用 DIY 系统帮助管理 1 型糖尿病的患者或家庭互动时参考。

相似文献

1
Do-It-Yourself (DIY) Systems in Diabetes: A Family and Provider Perspective.糖尿病的 DIY 系统:家庭和提供者的视角。
J Diabetes Sci Technol. 2020 Sep;14(5):917-921. doi: 10.1177/1932296820906204. Epub 2020 Mar 5.
2
Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals.DIY 人工胰腺系统:医疗专业人员新兴证据和见解综述。
J Diabetes Sci Technol. 2020 Sep;14(5):868-877. doi: 10.1177/1932296819894296. Epub 2019 Dec 17.
3
Using a Do-It-Yourself Artificial Pancreas: Perspectives from Patients and Diabetes Providers.使用 DIY 人工胰腺:患者和糖尿病提供者的观点。
J Diabetes Sci Technol. 2020 Sep;14(5):860-867. doi: 10.1177/1932296820942258. Epub 2020 Jul 17.
4
Do-It-Yourself Automated Insulin Delivery: A Leading Example of the Democratization of Medicine.自助式自动化胰岛素输送:医学民主化的典范。
J Diabetes Sci Technol. 2020 Sep;14(5):878-882. doi: 10.1177/1932296819890623. Epub 2019 Dec 26.
5
Do-It-Yourself (DIY) Closed Loop Systems: Perspectives of an Endocrinologist.自我施行(DIY)闭环系统:内分泌学家的观点。
J Diabetes Sci Technol. 2020 Nov;14(6):1104-1106. doi: 10.1177/1932296819890855. Epub 2019 Nov 26.
6
Health Care Provider Knowledge and Perceptions of FDA-Approved and Do-It-Yourself Automated Insulin Delivery.医疗保健提供者对 FDA 批准和 DIY 自动化胰岛素输送的知识和看法。
J Diabetes Sci Technol. 2020 Nov;14(6):1017-1021. doi: 10.1177/1932296819895567. Epub 2019 Dec 26.
7
"Do It Yourself" (DIY)-Automated Insulin Delivery (AID) Systems: Current Status From a German Point of View."DIY" 自动化胰岛素输送 (AID) 系统:从德国角度看当前现状。
J Diabetes Sci Technol. 2020 Nov;14(6):1028-1034. doi: 10.1177/1932296819889641. Epub 2019 Dec 25.
8
Peer Mentoring in the Do-it-Yourself Artificial Pancreas System Community.同行指导在 DIY 人工胰腺系统社区中的应用。
J Diabetes Sci Technol. 2020 Nov;14(6):1022-1027. doi: 10.1177/1932296819883876. Epub 2019 Oct 24.
9
Patient-Driven Diabetes Technologies: Sentiment and Personas of the #WeAreNotWaiting and #OpenAPS Movements.患者驱动的糖尿病技术:#WeAreNotWaiting 和 #OpenAPS 运动的情绪和人物。
J Diabetes Sci Technol. 2020 Nov;14(6):990-999. doi: 10.1177/1932296820932928. Epub 2020 Jul 4.
10
Glycemic Tracking Before and After Insulin Pump Initiation.胰岛素泵启动前后的血糖追踪
J Diabetes Sci Technol. 2020 Sep;14(5):970-971. doi: 10.1177/1932296820910506. Epub 2020 Mar 7.

引用本文的文献

1
Understanding Device Integrations Within Diabetes Apps: Mixed Methods Analysis of App Features and User Reviews.了解糖尿病应用程序中的设备集成:应用程序功能与用户评论的混合方法分析
JMIR Diabetes. 2025 May 27;10:e62926. doi: 10.2196/62926.
2
A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes.1 型糖尿病患者 DIY 自动化胰岛素输送系统(DIY AID)使用的范围综述。
PLoS One. 2022 Aug 11;17(8):e0271096. doi: 10.1371/journal.pone.0271096. eCollection 2022.
3
Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals.开源自动化胰岛素输送:面向医疗保健专业人员的国际共识声明和实用指南。
Lancet Diabetes Endocrinol. 2022 Jan;10(1):58-74. doi: 10.1016/S2213-8587(21)00267-9. Epub 2021 Nov 13.
4
Artificial Pancreas Technology Offers Hope for Childhood Diabetes.人工胰腺技术为儿童糖尿病带来希望。
Curr Nutr Rep. 2021 Mar;10(1):47-57. doi: 10.1007/s13668-020-00347-9. Epub 2021 Jan 7.

本文引用的文献

1
7. Diabetes Technology: .7. 糖尿病技术:。
Diabetes Care. 2020 Jan;43(Suppl 1):S77-S88. doi: 10.2337/dc20-S007.
2
7. Diabetes Technology: .7. 糖尿病技术: 。
Diabetes Care. 2019 Jan;42(Suppl 1):S71-S80. doi: 10.2337/dc19-S007.
3
Assessment of the Right-to-Try Law: The Pros and the Cons.“尝试权”法评估:利弊分析
J Nucl Med. 2018 Oct;59(10):1492-1493. doi: 10.2967/jnumed.118.216945. Epub 2018 Aug 10.
4
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.1型糖尿病患者使用混合闭环胰岛素输送系统的安全性。
JAMA. 2016 Oct 4;316(13):1407-1408. doi: 10.1001/jama.2016.11708.